UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 406

Sortiert nach

Chronic Pain Leads to Concomitant Noradrenergic Impairment and Mood Disorders

Biological psychiatry (1969), 2013, Vol.73 (1), p.54-62

2013

Volltextzugriff (PDF)

Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway

Neuropsychopharmacology (New York, N.Y.), 2018-09, Vol.43 (10), p.2028-2035

2018

Volltextzugriff (PDF)

Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants

Journal of neuroinflammation, 2018-09, Vol.15 (1), p.251-251, Article 251

2018

Volltextzugriff (PDF)

Quantification of endocannabinoids in postmortem brain of schizophrenic subjects

Schizophrenia research, 2013-08, Vol.148 (1), p.145-150

2013

Volltextzugriff (PDF)

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs

Frontiers in pharmacology, 2016-05, Vol.7, p.130-130

2016

Volltextzugriff (PDF)

Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus

Neuropharmacology, 2012-04, Vol.62 (5-6), p.1944-1953

2012

Volltextzugriff (PDF)

Identification of a serotonin/glutamate receptor complex implicated in psychosis

Nature, 2008-03, Vol.452 (7183), p.93-97

2008

Volltextzugriff (PDF)

Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function

The Journal of biological chemistry, 2012-12, Vol.287 (53), p.44301-44319

2012

Volltextzugriff (PDF)

Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophrenia

eLife, 2024-04, Vol.12

2024

Volltextzugriff (PDF)

Droplet-based bisulfite sequencing for high-throughput profiling of single-cell DNA methylomes

Nature communications, 2023-08, Vol.14 (1), p.4672-4672, Article 4672

2023

Volltextzugriff (PDF)

Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia

Journal of psychopharmacology (Oxford), 2019-09, Vol.33 (9), p.1132-1140

2019

Volltextzugriff (PDF)

Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

Journal of psychiatry & neuroscience, 2016-05, Vol.41 (3), p.E46-E55

2016

Volltextzugriff (PDF)

Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study

Addiction (Abingdon, England), 2014-12, Vol.109 (12), p.2071-2078

2014

Volltextzugriff (PDF)

Schizophrenia and depression, two poles of endocannabinoid system deregulation

Translational psychiatry, 2017-12, Vol.7 (12), p.1291-12, Article 1291

2017

Volltextzugriff (PDF)

Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia

Schizophrenia research, 2016-11, Vol.177 (1-3), p.88-97

2016

Volltextzugriff (PDF)

Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

Translational psychiatry, 2021-12, Vol.11 (1), p.643-643, Article 643

2021

Volltextzugriff (PDF)

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

Nature neuroscience, 2012-09, Vol.15 (9), p.1245-1254

2012

Volltextzugriff (PDF)

Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

Science signaling, 2016-01, Vol.9 (410), p.ra5

2016

Volltextzugriff (PDF)

Calcium-binding proteins are altered in the cerebellum in schizophrenia

PloS one, 2020-07, Vol.15 (7), p.e0230400-e0230400

2020

Volltextzugriff (PDF)

Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

Translational psychiatry, 2021-05, Vol.11 (1), p.302-302, Article 302

2021

Volltextzugriff (PDF)

Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia

Frontiers in pharmacology, 2020-03, Vol.11, p.344-344

2020

Volltextzugriff (PDF)

Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

European neuropsychopharmacology, 2013-08, Vol.23 (8), p.852-864

2013

Volltextzugriff (PDF)

Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram

Neuropharmacology, 2018-05, Vol.133, p.491-502

2018

Volltextzugriff (PDF)

G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

Nature communications, 2024-05, Vol.15 (1), p.4307-15, Article 4307

2024

Volltextzugriff (PDF)

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6016

2023

Volltextzugriff (PDF)

1 – 25 von 406

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(371)
Mit Volltextzugriff
(381)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Chronic Pain Leads to Concomitant Noradrenergic Impairment and Mood Disorders

Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway

Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants

Quantification of endocannabinoids in postmortem brain of schizophrenic subjects

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs

Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus

Identification of a serotonin/glutamate receptor complex implicated in psychosis

Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function

Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophrenia

Droplet-based bisulfite sequencing for high-throughput profiling of single-cell DNA methylomes

Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia

Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study

Schizophrenia and depression, two poles of endocannabinoid system deregulation

Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia

Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

Calcium-binding proteins are altered in the cerebellum in schizophrenia

Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia

Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram

G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia

Suchergebnisse filtern